{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:32:10Z","timestamp":1794047530571,"version":"4.8.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","award":["FDA"],"award-info":[{"award-number":["FDA"]}],"id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.vaccine.2017.11.039","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T07:47:01Z","timestamp":1511768821000},"page":"50-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990\u20132016"],"prefix":"10.1016","volume":"36","author":[{"given":"Pedro L.","family":"Moro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yenlik","family":"Zheteyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Barash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.11.039_b0005","unstructured":"Recombivax HB\u00ae hepatitis B vaccine (recombinant) package insert; 1989. <http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM110114.pdf>."},{"key":"10.1016\/j.vaccine.2017.11.039_b0010","unstructured":"ENGERIX-B\u00ae [Hepatitis B vaccine (recombinant)] package inserts; 1983. <https:\/\/www.gsksource.com\/pharma\/content\/dam\/GlaxoSmithKline\/US\/en\/Prescribing_Information\/Engerix-B\/pdf>."},{"key":"10.1016\/j.vaccine.2017.11.039_b0015","unstructured":"Twinrix\u00ae [Hepatitis A &hepatitis B (recombinant) vaccine] package insert; 2001. <http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM110079.pdf>."},{"key":"10.1016\/j.vaccine.2017.11.039_b0020","unstructured":"Comvax\u00ae [Haemophilus b conjugate (meningococcal protein conjugate) and hepatitis B (recombinant) vaccine] package insert; 1997. <http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM109869.pdf>."},{"key":"10.1016\/j.vaccine.2017.11.039_b0025","unstructured":"Pediarix\u00ae [Diphtheria and tetanus toxoid and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine] package insert; 2002. <http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM241874.pdf>."},{"issue":"RR-16","key":"10.1016\/j.vaccine.2017.11.039_b0030","first-page":"1","volume":"54","author":"Mast","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"RR-16","key":"10.1016\/j.vaccine.2017.11.039_b0035","first-page":"1","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2017.11.039_b0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2007-999384","article-title":"Hepatitis B vaccine in pregnancy: maternal and fetal safety","volume":"8","author":"Levy","year":"1991","journal-title":"Am J Perinatol"},{"issue":"6","key":"10.1016\/j.vaccine.2017.11.039_b0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ajog.2013.12.036","article-title":"Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant women","volume":"210","author":"Moro","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"36","key":"10.1016\/j.vaccine.2017.11.039_b0050","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)","volume":"33","author":"Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.039_b0055","unstructured":"Medical Dictionary for Regulatory Activities. Available at: <http:\/\/www.meddramsso.com\/> [accessed April 28, 2011]."},{"key":"10.1016\/j.vaccine.2017.11.039_b0060","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals. <http:\/\/www.ich.org\/products\/meddra.html>."},{"key":"10.1016\/j.vaccine.2017.11.039_b0065","first-page":"52252","article-title":"21 CFR Part 600.80. Postmarketing reporting of adverse experiences","volume":"62","author":"Food and Drug Administration","year":"1997","journal-title":"Federal Register"},{"key":"10.1016\/j.vaccine.2017.11.039_b0070","series-title":"Williams obstetrics","year":"2010"},{"key":"10.1016\/j.vaccine.2017.11.039_b0075","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(09)61877-8","article-title":"Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1N1 influenza vaccines","volume":"374","author":"Black","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.039_b0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.amepre.2013.10.010","article-title":"Vaccinations given during pregnancy, 2002\u20132009: a descriptive study","volume":"46","author":"Naleway","year":"2014","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.vaccine.2017.11.039_b0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ajog.2012.05.006","article-title":"Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women","volume":"207","author":"Zheteyeva","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.039_b0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40264-016-0482-1","article-title":"Surveillance of adverse events after seasonal influenza vaccination in pregnant women and their infants in the vaccine adverse event reporting system, July 2010\u2013May 2016","volume":"40","author":"Moro","year":"2017","journal-title":"Drug Saf"},{"issue":"21","key":"10.1016\/j.vaccine.2017.11.039_b0095","first-page":"580","article-title":"Guiding principles for development of ACIP recommendations for vaccination during pregnancy and breastfeeding","volume":"57","author":"CDC","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17316031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17316031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:16Z","timestamp":1759400716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17316031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0264410X17316031"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990\u20132016","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}